Antisense Phosphorodiamidate Morpholino Oligomers Targeted to an Essential Gene InhibitBurkholderia cepaciaComplex
Open Access
- 15 June 2010
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 201 (12) , 1822-1830
- https://doi.org/10.1086/652807
Abstract
(See the editorial commentary by Wiersinga, on pages 1786–1787.)Background. Members of the Burkholderia cepacia complex (Bcc) cause considerable morbiKeywords
This publication has 33 references indexed in Scilit:
- Impact of Burkholderia dolosa on Lung Function and Survival in Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Inhibition of Mycobacterium smegmatis Gene Expression and Growth Using Antisense Peptide Nucleic AcidsMicrobial Physiology, 2005
- Update on the Burkholderia cepacia complexCurrent Opinion in Pulmonary Medicine, 2005
- Antisense phosphorodiamidate morpholino oligomer inhibits viability of Escherichia coli in pure culture and in mouse peritonitisJournal of Antimicrobial Chemotherapy, 2005
- Antibacterial antisense.2005
- The multifarious, multireplicon Burkholderia cepacia complexNature Reviews Microbiology, 2005
- Antisense Phosphorodiamidate Morpholino Oligomer Length and Target Position Effects on Gene-Specific Inhibition inEscherichia coliAntimicrobial Agents and Chemotherapy, 2005
- Polar allele duplication for transcriptional analysis of consecutive essential genes: application to a cluster of Escherichia coli fatty acid biosynthetic genesJournal of Bacteriology, 1996
- Mouse model of X–linked chronic granulomatous disease, an inherited defect in phagocyte superoxide productionNature Genetics, 1995
- Pseudomonas cepacia infection in cystic fibrosis: An emerging problemThe Journal of Pediatrics, 1984